Incyte (INCY) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
29 Apr, 2026Executive summary
Annual meeting scheduled for June 8, 2026, at Wilmington, Delaware, at 10:00 am ET.
Proxy materials and annual report for 2025 are available online for review and voting.
Shareholders can vote electronically until June 7, 2026, or request paper materials by May 28, 2026.
Voting matters and shareholder proposals
Election of eight directors to serve until the 2027 annual meeting.
Advisory vote to approve named executive officer compensation.
Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026.
Board recommends voting FOR all nominees and proposals.
Board of directors and corporate governance
Eight director nominees listed for election, including Julian C. Baker and Jean-Jacques Bienaimé.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Incyte
- Q1 2026 net sales rose 20% to $1.10B, with strong product and pipeline performance.INCY
Q1 202629 Apr 2026 - 2025 saw robust growth, pipeline advancement, and strong governance ahead of key shareholder votes.INCY
Proxy filing29 Apr 2026 - 2025 revenue up 21% to $5.14B, core business ex-Jakafi up 53%, with strong 2026 outlook.INCY
Q4 202511 Apr 2026 - Pipeline advances and new launches position the business for strong post-Jakafi growth.INCY
Barclays 28th Annual Global Healthcare Conference11 Mar 2026 - INCA33989 and povorcitinib headline a pipeline poised to reshape hematology and immunology markets.INCY
Leerink Global Healthcare Conference 202610 Mar 2026 - Core growth and pipeline advances, led by Opzelura and Monjuvi, drive future outlook.INCY
TD Cowen 46th Annual Health Care Conference2 Mar 2026 - Q2 revenue up 9% to $1.044B, but Escient charges led to $445M net loss and $2B buyback.INCY
Q2 20242 Feb 2026 - Robust pipeline and strategic diversification aim to sustain growth beyond Jakafi's LOE.INCY
Goldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026 - Pipeline advances and commercial growth position the portfolio for long-term leadership.INCY
2024 Wells Fargo Healthcare Conference22 Jan 2026